An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.

The ECDC and the European Commission's Directorate-General for Health and Food Safety, at the invitation of the Maltese authorities, jointly carried out a country visit from 3 to 7 July 2017. The overall aim of the visit was to assist them in the further development and implementation of their national policies and strategies for tackling antimicrobial resistance based on a One Health perspective.

An ECDC country visit team conducted an assessment mission on 20-24 November 2017 to discuss antimicrobial resistance (AMR) issues in Belgium with the overall objective to provide an observation-based assessment of the situation in Belgium regarding prevention and control of AMR through prudent use of antibiotics and infection control.

An ECDC team conducted visits and meetings to discuss AMR issues in Romania with the overall objective of providing an evidence-based assessment of the situation in Romania regarding prevention and control of AMR through prudent use of antibiotics and infection control.

On 15-19 February 2016 an ECDC team conducted visits and meetings to discuss AMR issues in Spain, with the overall objective of providing an evidence-based assessment of the situation in Spain. The AMR situation in Spain poses a major public health threat to the country. Antimicrobial consumption in primary care and hospitals is among the highest in the EU/EEA and infection prevention and control and environmental cleaning measures vary significantly among hospitals and units.

An ECDC team conducted visits and meetings to Italy on 9-13 January 2017 to specifically discuss and assess the situation in the country regarding prevention and control of AMR. Observations from this ECDC country visit confirm that the AMR situation in Italian hospitals and regions poses a major public health threat to the country. If the current trends of carbapenem resistance and colistin resistance in gram-negative bacteria such as Klebsiella pneumoniae and A. baumannii are not reversed, key medical interventions will be compromised in the near future.

An ECDC team conducted visits and meetings to the country on 29 May - 2 June 2017, with the objective of providing an evidence-based assessment of the situation. Antibiotic consumption in Luxembourg is at the EU average in hospitals, but higher than the EU average in the community. The AMR levels in bacterial isolates from humans are at or below the EU average.

The Ministry of Health in Bulgaria invited ECDC to prepare an assessment of the current national HIV programme and to review the STI and Hepatitis surveillance system. Following discussions between ECDC and representatives of the Bulgarian national programme, it was decided to split the assessment into two separate country missions.

This mission report contains details of a visit to Romania by a team of multidisciplinary experts from ECDC and Norway, and the follow-up proposals.

This report summarises the results of a joint ECDC–European Commission mission team sent to review the epidemiological situation of yellow fever in Angola, following an outbreak in 2015-16.